| No. of guidelines (%) |
---|---|
Issues addressed | Â |
   Guideline addressed treatment for older patients | 8 (50) |
   Guideline addressed treatment for patients with multiple comorbid conditions | 9 (56.2) |
   Guideline addressed treatment for older patients with multiple comorbid conditions | 3 (18.8) |
Quality of evidence | Â |
   Quality of evidence discussed for older patients | 9 (56.2) |
   Quality of evidence discussed for patients with multiple comorbid conditions | 12 (75.0) |
   Quality of evidence discussed for older patients with comorbid conditions | 3 (18.8) |
Recommendations | Â |
   Specific recommendations for patients with one comorbid condition | 15 (93.8) |
   Specific recommendations for patients with two comorbid conditions | 3 (18.8) |
   Specific recommendations for patients with more than two comorbid conditions | 1 (6.2) |
Burden of treatment | Â |
   Time needed to treat to benefit from treatment in the context of life expectancy discussed | 9 (56.2) |
   Guideline discussed burden of comprehensive treatment on patients or caregivers | 6 (37.5) |
   Guideline discussed patients' financial burden | 4 (25) |
   Guideline discussed patients' quality of life | 13 (81.2) |
Patient preferences | Â |
   Guideline discussed patients' preferences | 9 (56.2) |
Medication | Â |
   Guideline discussed medications' side effects | 16 (100) |
   Guideline is adapted to possible medications' side effects | 12 (75) |
   Guideline discussed possible medications' interactions related to comorbidities | 10 (62.5) |